Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Efficacy of olanzapine in social anxiety disorder: a pilot study.

Barnett SD, Kramer ML, Casat CD, Connor KM, Davidson JR.

J Psychopharmacol. 2002 Dec;16(4):365-8.

PMID:
12503837
2.

Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.

J Clin Psychiatry. 2001 Apr;62(4):273-81.

PMID:
11379842
3.

Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.

Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V.

Am J Psychiatry. 1999 May;156(5):702-9.

PMID:
10327902
4.

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2000 Sep;57(9):841-9. Erratum in: Arch Gen Psychiatry 2002 Jan;59(1):91.

PMID:
10986547
5.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group..

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
6.

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.

Conley RR, Mahmoud R.

Am J Psychiatry. 2001 May;158(5):765-74. Erratum in: Am J Psychiatry 2001 Oct;158(10):1759.

PMID:
11329400
7.

Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.

Vaishnavi S, Alamy S, Zhang W, Connor KM, Davidson JR.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1464-9.

PMID:
17698275
8.

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

Potenza MN, Holmes JP, Kanes SJ, McDougle CJ.

J Clin Psychopharmacol. 1999 Feb;19(1):37-44.

PMID:
9934941
10.

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.

Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Breier A.

J Clin Psychopharmacol. 2001 Aug;21(4):389-97.

PMID:
11476123
11.

Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.

Poyurovsky M, Isaacs I, Fuchs C, Schneidman M, Faragian S, Weizman R, Weizman A.

Am J Psychiatry. 2003 Feb;160(2):297-302.

PMID:
12562576
12.

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.

Beasley CM Jr, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S.

Neuropsychopharmacology. 1996 Feb;14(2):111-23.

13.

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study.

Butterfield MI, Becker ME, Connor KM, Sutherland S, Churchill LE, Davidson JR.

Int Clin Psychopharmacol. 2001 Jul;16(4):197-203.

PMID:
11459333
14.

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.

Berk M, Ichim L, Brook S.

Int Clin Psychopharmacol. 1999 Nov;14(6):339-43.

PMID:
10565800
15.

A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.

Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzalez-Heydrich J, Risser RC, Nowlin ZM.

J Child Adolesc Psychopharmacol. 2001 Fall;11(3):239-50.

PMID:
11642474
16.
17.

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2002 Jan;59(1):62-9.

PMID:
11779284
18.

A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.

Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA.

Neuropsychopharmacology. 2004 Jan;29(1):133-45.

19.

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

Malone RP, Cater J, Sheikh RM, Choudhury MS, Delaney MA.

J Am Acad Child Adolesc Psychiatry. 2001 Aug;40(8):887-94.

PMID:
11501687
20.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. Erratum in: Arch Gen Psychiatry. 2004 Feb;61(2):176.

PMID:
14609883

Supplemental Content

Support Center